NanoHive Medical closed a venture debt round to support continued adoption of its proprietary Soft Titanium® interbody fusion devices. The debt was provided by Kenston Capital Partners and its affiliates with Outcome Capital acting as strategic and financial advisor to NanoHive Medical.
NanoHive’s highly differentiated lattice structure is designed to provide enhanced visualization and reduced density as compared to alternatives, while also achieving sufficient durability and strength for biomechanical loads. Specifically designed geometry using a rhombic dodecahedron cell structure creates a base structure similar to cancellous bone, and provides ideal biomechanical elastic modulus properties.
Manufactured with 3D-printed titanium, the NanoHive interbody portfolio spans anterior and posterior lumbar, as well as cervical applications.
“This capital infusion allows the company to capture the attention of leading surgeons and convert them to our best-in-class portfolio more aggressively. As we continue to produce consecutive month-over-month record sales, Kenston Capital’s participation enables this trend to continue,” said Patrick O’Donnell, CEO of NanoHive Medical.
NanoHive Medical closed a venture debt round to support continued adoption of its proprietary Soft Titanium® interbody fusion devices. The debt was provided by Kenston Capital Partners and its affiliates with Outcome Capital acting as strategic and financial advisor to NanoHive Medical.
NanoHive Medical closed a venture debt round to support continued adoption of its proprietary Soft Titanium® interbody fusion devices. The debt was provided by Kenston Capital Partners and its affiliates with Outcome Capital acting as strategic and financial advisor to NanoHive Medical.
NanoHive’s highly differentiated lattice structure is designed to provide enhanced visualization and reduced density as compared to alternatives, while also achieving sufficient durability and strength for biomechanical loads. Specifically designed geometry using a rhombic dodecahedron cell structure creates a base structure similar to cancellous bone, and provides ideal biomechanical elastic modulus properties.
Manufactured with 3D-printed titanium, the NanoHive interbody portfolio spans anterior and posterior lumbar, as well as cervical applications.
“This capital infusion allows the company to capture the attention of leading surgeons and convert them to our best-in-class portfolio more aggressively. As we continue to produce consecutive month-over-month record sales, Kenston Capital’s participation enables this trend to continue,” said Patrick O’Donnell, CEO of NanoHive Medical.
Copy to clipboard 
